Latest news
MSEK 5 grant from VINNOVA
The Swedish Governmental Agency for Innovation Systems, Vinnova, has decided to fund a 3-year Scandivir project regarding diagnostics and treatment of virally induced obesity with MSEK 5. The project is carried out by Dr. Catharina Lavebratt at Center for Molecular Medicine (CMM) and Karolinska Institutet in Sweden.
ELISA test being prepared for commercialization
In May, 2009, the Board of Scandivir concluded that the company's R&D work has resulted in a commercial solution for diagnosis of the obesity virus Ad-36. An ELISA test, the most common technical platform used by diagnostic laboratories all over the world, is now being optimized for accuracy and industrial production, with commercialization as the next step. This is not only Scandivir's first product, but it will also be the first ELISA test for Ad-36 on the market.
Kallelse till bolagsstämma 2010-06-30
Hämta kallelsen här.
Anmälan och fullmakt.
Scandivirs årsredovisning 2009.
Brev till aktieägare [ doc | pdf ].
Information about cookies
According to Swedish law a web site that uses cookies must provide information about cookies.
This web sites make use of cookies. A cookie is a file that is saved locally on your harddrive. According to the Swedish Law of electronic communication, every visitor to a web site with cookies must be informed about
- that the web site make use of cookies,
- what the cookise are used for, and
- how cookies can be avoided.
On this web site cookies are used for strict technical reasons. Web browsers can be set to neglect cookies or to inform the user that a cookie is to be set. Due to the technology used on this web site, it will not work without cookies.
More information
For more information, read Lag om elektronisk kommunikation, SFS 2003:389, only available in Swedish.
